VIRGINIA COMMONWEALTH UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vcu.edu
NOURISH+: Nourishing Our Understanding of Role Modeling to Improve Support and Health
Not Applicable
Completed
- Conditions
- Overweight and Obesity
- Interventions
- Behavioral: NOURISH+Behavioral: Wellness Group
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2018-02-22
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 730
- Registration Number
- NCT01361243
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Brief Computerized Feedback for Smokers in Recovery
Not Applicable
Completed
- Conditions
- Smoking
- Interventions
- Other: Brief computerized feedbackOther: Resources only (control)
- First Posted Date
- 2011-03-30
- Last Posted Date
- 2012-11-15
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 151
- Registration Number
- NCT01325727
- Locations
- 🇺🇸
Substance Abuse Addiction and Recovery Alliance Center, Midlothian, Virginia, United States
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure
- First Posted Date
- 2011-02-21
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 11
- Registration Number
- NCT01300650
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Not Applicable
Completed
- Conditions
- Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage II Breast Cancer
- Interventions
- Procedure: Neoadjuvant TherapyProcedure: Therapeutic Conventional SurgeryOther: Laboratory Biomarker AnalysisGenetic: Gene Expression AnalysisDrug: Systemic ChemotherapyDrug: Aromatase Inhibition Therapy
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 59
- Registration Number
- NCT01293032
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸Cone Health Cancer Center, Greensboro, North Carolina, United States
🇺🇸Forsyth Regional Cancer Center, Charlotte, North Carolina, United States
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Phase 1
Terminated
- Conditions
- Salivary Gland Squamous Cell CarcinomaStage III Salivary Gland CancerStage III Squamous Cell Carcinoma of the OropharynxStage IV Verrucous Carcinoma of the Oral CavityStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Salivary Gland CancerStage IV Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the Lip and Oral Cavity
- Interventions
- Radiation: intensity-modulated radiation therapyRadiation: image-guided adaptive radiation therapyOther: 3'-deoxy-3'-[18F]fluorothymidineProcedure: positron emission tomography/computed tomographyRadiation: fludeoxyglucose F 18
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2016-10-31
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 3
- Registration Number
- NCT01283178
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Behavioral Incentives to Increase Exercise in Cocaine Dependent Women
Not Applicable
Completed
- Conditions
- Cocaine Dependence
- Interventions
- Behavioral: Education ControlBehavioral: Behavioral Incentives
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2014-12-18
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 26
- Registration Number
- NCT01283191
- Locations
- 🇺🇸
Rubicon, Inc., Richmond, Virginia, United States
Nerve Growth Factor in Chronic Pancreatitis
Completed
- Conditions
- Chronic Pancreatitis
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 38
- Registration Number
- NCT01255917
- Locations
- 🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Phase 2
Terminated
- Conditions
- Metabolic SyndromeNonalcoholic Fatty Liver Disease
- Interventions
- Drug: Sodium Octanoate Breath Test
- First Posted Date
- 2010-11-19
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 61
- Registration Number
- NCT01244503
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)
Phase 2
Completed
- Conditions
- Mild Traumatic Brain InjuryPost-Concussive Syndrome
- Interventions
- Procedure: Hyperbaric Oxygen Therapy
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2013-08-27
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 60
- Registration Number
- NCT01220713
- Locations
- 🇺🇸
Naval Medical Center Portsmouth, Portsmouth, Virginia, United States
🇺🇸Hunter Holmes McGuire Veterans' Affairs Medical Center, Richmond, Virginia, United States
🇺🇸Virginia Commonwealth University, Richmond, Virginia, United States
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Other: questionnaire administrationOther: laboratory biomarker analysis
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 11
- Registration Number
- NCT01204255
- Locations
- 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath